117 related articles for article (PubMed ID: 19367200)
1. [Early detection of smoking related chronic obstructive pulmonary disease in Vietnam].
Duong-Quy S; Hua-Huy T; Mai-Huu-Thanh B; Doan-Thi-Quynh N; Le-Quang K; Nguyen-Van H; Phan-Van D; Tran-Dinh H; Reboud P; Dinh-Xuan AT; Homasson JP
Rev Mal Respir; 2009 Mar; 26(3):267-74. PubMed ID: 19367200
[TBL] [Abstract][Full Text] [Related]
2. Voluntary lung function screening to reveal new COPD cases in southern Italy.
Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
[TBL] [Abstract][Full Text] [Related]
3. [Early detection of COPD in smoking cessation outpatients].
Rouatbi S; Mezghani S; Khalfallah M; Benzarti M
Tunis Med; 2015 Jul; 93(7):458-64. PubMed ID: 26757504
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
[TBL] [Abstract][Full Text] [Related]
5. Simplified COPD screening: validation of the PiKo-6® in primary care.
Frith P; Crockett A; Beilby J; Marshall D; Attewell R; Ratnanesan A; Gavagna G
Prim Care Respir J; 2011 Jun; 20(2):190-8, 2 p following 198. PubMed ID: 21597667
[TBL] [Abstract][Full Text] [Related]
6. [Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care].
Clotet J; Gómez-Arbonés X; Ciria C; Albalad JM
Arch Bronconeumol; 2004 Apr; 40(4):155-9. PubMed ID: 15030729
[TBL] [Abstract][Full Text] [Related]
7. VitalQPlus: a potential screening tool for early diagnosis of COPD.
Sui CF; Ming LC; Neoh CF; Ibrahim B
Int J Chron Obstruct Pulmon Dis; 2015; 10():1613-22. PubMed ID: 26316735
[TBL] [Abstract][Full Text] [Related]
8. FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies.
Solidoro P; Braido F; Baratta F; Bagnasco D; Esposito R; Aggeri M; Brusa P
Panminerva Med; 2013 Mar; 55(1):87-92. PubMed ID: 23474666
[TBL] [Abstract][Full Text] [Related]
9. [Early detection of COPD in smokers from Warsaw using spirometric screening].
Bednarek M; Pływaczewski R; Górecka D; Puścińska E; Nowiński A; Zieliński J
Pneumonol Alergol Pol; 2002; 70(3-4):139-47. PubMed ID: 12271961
[TBL] [Abstract][Full Text] [Related]
10. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.
Lundgren FL; Cabral MM; Clímaco DC; de Macedo LG; Coelho Mde A; Dias AL
J Bras Pneumol; 2007; 33(2):148-51. PubMed ID: 17724533
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of The Piko-6 Portable Device for Early COPD Detection in Primary Care.
Hidalgo Sierra V; Hernández Mezquita MÁ; Palomo Cobos L; García Sánchez M; Castellanos RD; Jodra Sánchez S; Cordovilla Pérez R; Barrueco Ferrero M
Arch Bronconeumol (Engl Ed); 2018 Sep; 54(9):460-466. PubMed ID: 29880313
[TBL] [Abstract][Full Text] [Related]
12. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers].
Jaén Díaz JI; de Castro Mesa C; Gontán García-Salamanca MJ; López de Castro F
Arch Bronconeumol; 2003 Dec; 39(12):554-8. PubMed ID: 14636492
[TBL] [Abstract][Full Text] [Related]
14. The use of microspirometry in detecting lowered FEV1 values in current or former cigarette smokers.
Rytila P; Helin T; Kinnula V
Prim Care Respir J; 2008 Dec; 17(4):232-7. PubMed ID: 18830521
[TBL] [Abstract][Full Text] [Related]
15. Gender and chronic obstructive pulmonary disease in high-risk smokers.
de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
[TBL] [Abstract][Full Text] [Related]
17. The FEV1/FEV6 predicts lung function decline in adult smokers.
Enright RL; Connett JE; Bailey WC
Respir Med; 2002 Jun; 96(6):444-9. PubMed ID: 12117045
[TBL] [Abstract][Full Text] [Related]
18. Early detection of COPD patients in GOLD 0 population: an observational non-interventional cohort study - MARKO study.
Vrbica Ž; Labor M; Gudelj I; Labor S; Jurić I; Plavec D;
BMC Pulm Med; 2017 Feb; 17(1):36. PubMed ID: 28187733
[TBL] [Abstract][Full Text] [Related]
19. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
20. Comparison of forced expiratory volume in one second (FEV1) among asymptomatic smokers and non-smokers.
Khan A; Shabbir K; Ansari JK; Zia N
J Pak Med Assoc; 2010 Mar; 60(3):209-13. PubMed ID: 20225780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
